Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Lynk Pharmaceuticals Co., Ltd

Clinical trials sponsored by Lynk Pharmaceuticals Co., Ltd, explained in plain language.

Upcoming readouts

Trials from this sponsor expected to report results within the next 12 months.

New hope for back pain: experimental drug LNK01001 enters final trial phase Results expected Nov 2026 (estimated)

Browse trials soon ready across all sponsors →

Trials to join now! 1 Not yet finished but already full! 1 Completed 2

New hope for arthritis sufferers: experimental drug shows promise in Late-Stage trial

Disease control Ongoing

This study tests a new oral drug called LNK01001 (Zemprocitinib) in 430 adults with moderate-to-severe rheumatoid arthritis who have not improved with other biologic treatments. Participants receive either the drug or a placebo for 24 weeks, followed by a long-term safety extensi…

Phase 3 • Sponsor: Lynk Pharmaceuticals Co., Ltd • Aim: Disease control

Last updated Jun 27, 2026 08:12 UTC